Search

M2 PRESSWIRE-February 22, 2024-: Smoking Cessation and Nicotine Addiction Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Pfizer, Inc., Cipla, Novartis, GlaxoSmithKline (C)1994-2024 [...]

Richmond: The Cytomegalovirus (CMV) Treatment Market report focuses on the pharmaceutical and healthcare industries, specifically targeting infections caused by the common herpesvirus virus. The market is expected to grow due [...]

DUBLIN: Research and Markets has issued the following news release: The 'Somatostatin Analogs Market Report: Trends, Forecast and Competitive Analysis to 2030' report has been added to ResearchAndMarkets.com's offering. The [...]

DUBLIN, Feb. 16, 2024 /PRNewswire/ -- The https://www.researchandmarkets.com/report/somatostatin-analogs?utm_source=CI&utm_medium=PressRelease&utm_code=pxlv3l&utm_campaign=1936955+-+Global+Somatostatin+Analogs+Market+Report+2024-2030+Featuring+Major+Players+-+Novartis%2c+Sun+Pharma%2c+Midatech+Pharma%2c+Ipsen+Pharma%2c+Chiasma%2c+Peptron%2c+Dauntless+Pharma%2c+Camurus%2c+Teva%2c+and+Pfizer&utm_exec=chdomspi report has been added toResearchAndMarkets.com's offering. The global somatostatin analogs market is expected to reach an estimated $8.3 billion by 2030 with [...]

M2 PRESSWIRE-February 15, 2024-: CD-19 Market to Witness Significant Growth During the Study Period (2019-32), Assesses DelveInsight | Horizon Therapeutics, MorphoSys, Incyte, Novartis, Bristol-Myers Squibb, Legend Biotech, Janssen (C)1994-2024 M2 [...]

M2 PRESSWIRE-February 14, 2024-: Sphingosine 1 Phosphate Receptor (S1PR) Modulators Market to Witness Significant Growth During the Study Period (2019-2032), Assesses DelveInsight | Major Players - Celgene (BMS)), Pfizer, Novartis [...]

M2 PRESSWIRE-February 14, 2024-: Lupus Nephritis Market Expected to Witness Significant Expansion Throughout Forecast Period (2023-2032) - Delveinsight | Roche, Equillium, Argenx, AstraZeneca, Novartis, RemeGen, Annexon (C)1994-2024 M2 COMMUNICATIONS RDATE:13022024 [...]

DUBLIN: Research and Markets has issued the following news release: The 'Biologic Therapeutic Drugs: Technologies and Global Markets' report has been added to ResearchAndMarkets.com's offering. The biologics market is wide-ranging [...]

M2 PRESSWIRE-February 8, 2024-: Biologic Therapeutic Drugs: Technologies and Global Market Report 2024, with Company Profiles of Amgen, Abbive, Eli Lilly, Novartis and Glaxosmithkline (C)1994-2024 M2 COMMUNICATIONS RDATE:08022024 The 'Biologic [...]

M2 PRESSWIRE-February 8, 2024-: Sjogren's Syndrome Market Poised for Phenomenal Expansion During the Forecast Period (2023-32) - DelveInsight | Gilead, Daiichi Sankyo, Bayer, Vielabio, Remegen, Pfizer, Novartis, Genentech (C)1994-2024 M2 [...]

M2 PRESSWIRE-February 6, 2024-: CFZ533 for Sjögren's Syndrome: Market Size and Share Analysis and Competitive Landscape by DelveInsight | Key Players - Novartis (C)1994-2024 M2 COMMUNICATIONS RDATE:05022024 DelveInsight has released [...]

WILMINGTON, Mass. -- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Reshema Kemps-Polanco, Executive Vice President and Chief Commercial Officer, Novartis US, to its Board of [...]

The CAR-T cell therapy market is expected to grow significantly in the coming years, driven by the increasing incidence of cancer and the growing demand for personalized cancer treatments. The [...]

M2 PRESSWIRE-January 18, 2024-: Tendinopathy Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Novartis, ZARS Pharma Inc., Merck Sharp, Erasmus Medical Center, CTM [...]

M2 PRESSWIRE-January 17, 2024-: Congestive Heart Failure market size is expected to grow at a decent CAGR by 2034, estimates DelveInsight | Novartis, Boehringer Ingelheim, Eli Lilly, Bayer, Merck, AstraZeneca, [...]

NEW YORK, Jan. 17, 2024 /PRNewswire/ -- Thehttps://www.technavio.com/report/antimicrobial-therapeutics-market-size-industry-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=T2023_vrd_wk03_2024_021_rep&utm_content=IRTNTR43391 is expected to grow byUSD 51.4 billion from 2022 to 2027. In addition, the momentum of the market will progress at aCAGR [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Sjogren's Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, Sjogren's syndrome emerging drugs, [...]

NEW YORK, Jan. 16, 2024 /PRNewswire/ -- Thehttps://www.technavio.com/report/report/osteoarthritis-therapeutics-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk03_2024_016_rep&utm_content=IRTNTR43212 size is expected to grow byUSD 3.96 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

NEW YORK, Jan. 15, 2024 /PRNewswire/ -- Thehttps://www.technavio.com/report/allergy-immunotherapies-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk03_2024_019_rep&utm_content=IRTNTR41320 is expected to grow byUSD 1.01 billion from 2022 to 2027. In addition, the momentum of the market will progress at aCAGR [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: DelveInsight's Gene Therapy Market Insights report provides the current and forecast market analysis, individual leading gene therapy companies' [...]

(GlobeNewswire) - The global dry eye syndrome market size was USD 5.32 billion in 2022 and is expected to register a revenue CAGR of 7.3% during the forecast period. Increasing [...]

The achondroplasia market size shall grow during the forecast period (2023--2032) due to the launch of upcoming therapies and the increasing cases of achondroplasia. This achondroplasia market is expected to [...]

NEW YORK, Jan. 8, 2024 /PRNewswire/ -- The https://www.technavio.com/report/contact-lens-solutions-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_latestNewN1_023wk2_2024_INT1_rep&utm_content=IRTNTR74234 is estimated to grow byUSD 540.94 million from 2023 to 2028, according to Technavio. The market is estimated to grow at [...]

NEW YORK, Jan. 8, 2024 /PRNewswire/ -- The https://www.technavio.com/report/castration-resistant-prostate-cancer-crpc-treatment-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_023wk2_2024_INT1_rep&utm_content=IRTNTR77080 is expected to grow byUSD 5.98 billion from 2023 to 2028. In addition, the momentum of the market will progress at [...]

NEW YORK, Jan. 5, 2024 /PRNewswire/ -- The https://www.technavio.com/report/active-pharmaceutical-ingredients-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_week1_24_TI_019_rep&utm_content=IRTNTR40608 is expected to grow byUSD 86.47 billion from 2023 to 2028. In addition, the momentum of the market will progress at [...]

NEW YORK, Jan. 4, 2024 /PRNewswire/ -- The https://www.technavio.com/report/cancer-immunotherapy-market-industry-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_week1_24_TI_019_rep&utm_content=IRTNTR71598 is expected to grow byUSD 38.57 billion from 2022 to 2027. In addition, the momentum of the market will progress at [...]

The growth of the metastatic castrate-resistant prostate cancer market is expected to be driven by the expected rising prevalence of prostate cancer cases due to rapidly aging population and growing [...]

DUBLIN, Dec. 19, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5876507/global-markets-treatments-syndromes-progressive?utm_source=CI&utm_medium=PressRelease&utm_code=nlds89&utm_campaign=1919986+-+Global+Progressive+Ataxia+and+Weakness+Disorders+Treatment+Market+Report%3a+Focus+on+Key+Players+Novartis%2c+Pfizer%2c+Sanofi%2c+GlaxoSmithKline%2c+Roche%2c+Merck%2c+Takeda+Pharmaceuticals+and+Abbott+Laboratories&utm_exec=cari18prd report has been added toResearchAndMarkets.com's offering. Neurological disorders are surging; this trend is particularly noticeable in syndromes associated with progressive ataxia and [...]

New York, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Market Overview and Report Coverage The https://www.globenewswire.com/Tracker?data=W3GnlkiSryqhGj_sxHjc-XKkDSGMnVzruSDASQ5c564370roi37EIReCUBp26JVBdrJxAAoqKuisVitvzHC0XST5fcSqIzHrdNDftUSwSCoUFaus7Cl8XTe1AMyhPygSAJESM8C8DnJOc5W73wruNw==size is subject to in-depth analysis through market research reports, providing valuable insights into current conditions. [...]

M2 PRESSWIRE-December 14, 2023-: Autosomal Dominant Polycystic Kidney Disease Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Pfizer, Otsuka Pharma, Palladio Biosciences, Novartis (C)1994-2023 M2 [...]

DUBLIN: Research and Markets has issued the following news release: The 'Melanoma Therapeutics: Global Markets' report has been added to ResearchAndMarkets.com's offering. The global market for melanoma treatment was estimated [...]

DUBLIN, Dec. 13, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/report/melanoma-drug?utm_source=CI&utm_medium=PressRelease&utm_code=f5sgbl&utm_campaign=1917899+-+Global+Melanoma+Treatment+Market+Report+2023%2c+Featuring+Comprehensive+Profiles+of+Leading+Players+including+Amgen%2c+Roche%2c+Merck+%26+Co.%2c+Pfizer+Inc.%2c+BMS+and+Novartis&utm_exec=cari18prd report has been added toResearchAndMarkets.com's offering. The global market for melanoma treatment was estimated to reach $6.8 billion in 2022 and is [...]

M2 PRESSWIRE-December 13, 2023-: Knee Osteoarthritis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Novartis, Biosplice Therapeutic, Sorrento Therapeutic, Eli [...]

M2 PRESSWIRE-December 12, 2023-: Non-Hodgkin's Lymphoma Market Poised for Extraordinary Growth During the Forecast Period (2023-32), Asserts DelveInsight | AbbVie, Angiocrine, AstraZeneca, Autolus, Genmab, Loxo Oncology, Novartis (C)1994-2023 M2 COMMUNICATIONS [...]

NEW YORK, Dec. 12, 2023 /PRNewswire/ -- Thehttps://www.technavio.com/report/report/alzheimers-disease-therapeutics-market-industry-size-analysis?utm_source=prnewswire&utm_medium=prnewswire&utm_campaign=T2023_VRD_wk50_2023_016_rep&utm_content=IRTNTR40742 size is expected to grow byUSD 5.41 billion from 2023 to 2028. In addition, the momentum of the market will progress at [...]

M2 PRESSWIRE-December 11, 2023-: ADPKD Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Palladio Biosciences, Kadmon, Novartis, Pfizer, Otsuka Pharma, XORTX Therapeutics, Sanofi (C)1994-2023 [...]

M2 PRESSWIRE-December 8, 2023-: Bone Metastasis in Solid Tumors Market 2032 - Epidemiology, Pipeline, Therapies and Recent Regulatory Approvals by DelveInsight | Companies: Mabwell Bioscience, Hoffmann-La Roche, Novartis, Upjohn (C)1994-2023 [...]

DUBLIN, Dec. 7, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/5910676/tyrosine-kinase-inhibitors-global-market-outlook?utm_source=CI&utm_medium=PressRelease&utm_code=97ngnl&utm_campaign=1917108+-+Global+Tyrosine+Kinase+Inhibitors+Market+Report+2023-2028%2c+Featuring+Profiles+of+Major+Players+including%c2%a0Astrazeneca%2c+Bayer%2c+Bristol-Myers+Squibb+%2c+Eisai%2c+F.+Hoffmann-La+Roche%2c+Novartis+and+Pfizer&utm_exec=cari18prd report has been added toResearchAndMarkets.com's offering. The report provides an overview of the global tyrosine kinase inhibitor market and analyzes market trends. [...]

M2 PRESSWIRE-December 7, 2023-: Ascites Market Anticipates Steady Growth Throughout the Forecast (2023-2032), Reports DelveInsight | Companies Include AstraZeneca plc, Pfizer Inc., Novartis AG, Baxter, and Roche (C)1994-2023 M2 COMMUNICATIONS [...]

The total metastatic castration-resistant prostate cancer market size in the 7MM was estimated to be nearly USD 2.1 billion in 2022. The market size of the metastatic castration-sensitive prostate cancer [...]

M2 PRESSWIRE-November 29, 2023-: Choroidal Neovascularization Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Abbvie, Sylentis, Ixoberogene soroparvovec, Novartis, Hoffmann-La Roche (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-November 29, 2023-: Insights on Desmoid Tumors Market 2032: Epidemiological Trend, FDA, EMA, PDMA Approvals, Pipeline Therapies by DelveInsight | Pfizer, Novartis, SpringWorks Therapeutics, Ayala Pharmaceuticals, Iterion (C)1994-2023 M2 [...]

M2 PRESSWIRE-November 29, 2023-: Primary Myelofibrosis Market to Show a Rise During the Forecast Period, Asserts DelveInsight | Companies - Teva Pharmaceutical, Pfizer, Roche, Novartis (C)1994-2023 M2 COMMUNICATIONS RDATE:28112023 DelveInsight's [...]

M2 PRESSWIRE-November 29, 2023-: Chiari Malformation Market to Show a Rise During the Forecast Period, asserts DelveInsight | Companies - Roche, Pfizer, Novartis (C)1994-2023 M2 COMMUNICATIONS RDATE:28112023 DelveInsight's 'Chiari Malformation- [...]

M2 PRESSWIRE-November 24, 2023-: Estimating the CAGR of 12.24%: Global Active Pharmaceutical Ingredient Market Projections till 2028, DelveInsight Analytics | Sun Pharma, Merck, Teva Pharma, Pfizer, Novartis, Boehringer Ingelheim (C)1994-2023 [...]